Roundhill Weekly T Bill ETF (WEEK) Historical

Lavras Gold Corp. President & CEO Michael Durose talked with Proactive's Angela Harmantas from the PDAC conference on Toronto about the company’s latest developments at the Lavras do Sul (LDS) Project in Brazil. The company, a gold exploration firm, currently holds around 1 million ounces across two of 24 exploration targets. Durose outlined the key 2024 milestones, including 17,000 meters of drilling across key areas such as Butiá, Fazenda do Posto, and Caneleira. A major highlight was the Almeria discovery, where drilling intersected 56 meters at 1 gram per ton of gold from surface. Looking ahead, Lavras Gold is focused on infill drilling at Butiá to define a potential mineable resource and step-out drilling at Fazenda do Posto to determine the mineralization limits. The company is also conducting metallurgical test work at Butiá, which will later extend to Fazenda do Posto. Durose emphasized that additional drilling results and exploration at Caneleira will be major catalysts for the company in 2024, potentially expanding the known mineralization footprint. #LavrasGold #GoldExploration #MiningNews #GoldStocks #BrazilMining #JuniorMining #DrillResults #GoldDiscovery #Investing #MiningInvestments

GraphEnergyTech CEO Dr Thomas Baumeler discussed a collaboration with the Taiwan Perovskite Solar Corporation, Taiwan’s prestigious Industrial Technology Research Institute and the University of Cambridge. The project is supported by an Innovate UK grant worth nearly £900,000. Known as GETPSC (Graphene Electrode Technology for Perovskite Solar Cells), Baumeler explained that current solar cells rely on expensive silver electrodes, which degrade when in contact with Perovskite Solar Cells. GraphEnergyTech, a Frontier IP Group PLC (AIM:FIPP) portfolio company, aims to replace these with graphene-based electrodes, offering a more stable and cost-effective alternative. "Graphene is one of the most interesting materials out there," he said, highlighting its durability and lower cost compared to silver. Perovskite Solar Cells are considered the next major advancement in photovoltaics due to their efficiency and simpler manufacturing process. However, industrial-scale adoption has been hindered by the lack of a viable nonmetallic electrode—something GraphEnergyTech aims to solve. Baumeler also noted that GraphEnergyTech is working on replacing silver electrodes in traditional silicon-based solar cells while exploring applications for its conductive carbon-based technology in batteries, supercapacitors, and electronics. For more insights into renewable energy innovations, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and enable notifications for future updates. #GraphEnergyTech #SolarEnergy #GrapheneTech #PerovskiteSolar #RenewableEnergy #CleanEnergy #TechInnovation #SolarCells #GreenTechnology #EnergyStorage

Lisata Therapeutics Inc (NASDAQ:LSTA) CEO David Mazzo talked with Proactive about the company’s strategic collaboration with GATC Health, a leader in artificial intelligence-driven drug discovery. Mazzo explained that GATC’s technology, which is recognized by Lloyd’s of London for clinical trial risk assessment, will be used to analyze Lisata’s lead candidate, certepetide, and identify potential new drug combinations. Mazzo highlighted that this collaboration will optimize Lisata’s ongoing cancer research, including trials in pancreatic ductal adenocarcinoma, cholangiocarcinoma, and other cancers. He noted that GATC’s AI technology can perform billions of simulations rapidly, potentially reducing the cost and risk of drug development. Discussing Lisata’s 2025 outlook, Mazzo described it as a "data-rich year," with upcoming results from the ASCEND trial and other studies. He emphasized the potential for certepetide in combination with immunotherapy and the company’s ongoing discussions with regulatory agencies and potential partners. To watch more interviews like this, visit Proactive’s YouTube channel. Don't forget to like this video, subscribe, and enable notifications for future updates. #LisataTherapeutics #Biotech #CancerResearch #AIinHealthcare #DrugDevelopment #ClinicalTrials #GATCHealth #Pharma #Oncology #Investing

National Stock Exchange of Australia CEO Max Cunningham talked with Proactive's Angela Harmantas from the PDAC conference in Toronto about the exchange’s role in the Australian market, its focus on mining companies, and its expansion plans. Cunningham explained that the NSX is one of two active stock exchanges in Australia with a tier-one license, allowing it to serve all investors, including retail. He highlighted that around one-third of the exchange’s listings are mining-related, with strong growth potential in the sector. Cunningham noted that NSX is working to fill a gap in the Australian venture market and is focusing on attracting mining companies, especially from regions like Perth. He also emphasized the importance of international relationships, mentioning cross-listing agreements with Canadian exchanges such as the CSE and TSX, as well as OTC Markets. Looking ahead to 2025, Cunningham discussed the challenges of IPOs due to regulatory hurdles and capital-raising difficulties. Instead, the NSX is prioritizing direct listings, which allow companies to go public without raising capital upfront. He stated that NSX is seeing increased interest from firms moving from the incumbent Australian exchange, as well as from Canadian companies seeking dual listings. #NSX #StockMarket #MiningStocks #IPOs #DirectListings #PDAC2025 #Investing #AustralianMarkets #DualListings #CapitalMarkets